Cadrenal Therapeutics Inc (CVKD)

Dec 14, 2025

Understanding the Setup: (CVKD) and Scalable Risk - news.stocktradersdaily.com

Dec 14, 2025

Dec 14, 2025

Cadrenal Therapeutics acquires VLX-1005 from Veralox - MSN

Dec 14, 2025

Dec 12, 2025

Cadrenal's Quiet Expansion Play Is Starting to Get Loud - The Joplin Globe

Dec 12, 2025

Dec 12, 2025

Cadrenal Therapeutics (NASDAQ: CVKD) adds HIT, Factor XIa drugs in quiet expansion - Stock Titan

Dec 12, 2025

Dec 12, 2025

Cadrenal's Anticoagulation Platform Is Expanding in a $40 Billion Market - ACCESS Newswire

Dec 12, 2025

Dec 12, 2025

Cadrenal Therapeutics (NASDAQ: CVKD) builds multi-asset anticoagulation platform in $40B market - Stock Titan

Dec 12, 2025

Dec 12, 2025

Cadrenal Therapeutics acquires late-stage drug assets from Maryland biotech - The Business Journals

Dec 12, 2025

Dec 11, 2025

Cadrenal Therapeutics acquires VLX-1005 for heparin-induced thrombocytopenia - TipRanks

Dec 11, 2025

Dec 11, 2025

Cadrenal Therapeutics acquires first-in-class HIT treatment from Veralox - Investing.com

Dec 11, 2025

Dec 11, 2025

Cadrenal Therapeutics Acquires VLX-1005 from Veralox - TipRanks

Dec 11, 2025

Dec 11, 2025

Cadrenal Therapeutics acquires first-in-class HIT treatment from Veralox By Investing.com - Investing.com Canada

Dec 11, 2025

Dec 11, 2025

Cadrenal Therapeutics acquires VLX-1005, a first-in-class Phase 2 12-LOX inhibitor for patients with heparin-induced thrombocytopenia - marketscreener.com

Dec 11, 2025

Dec 11, 2025

Cadrenal Therapeutics (Nasdaq: CVKD) adds Phase 2 12-LOX HIT therapy with FDA Fast Track - Stock Titan

Dec 11, 2025

Dec 06, 2025

Cadrenal Therapeutics (CVKD) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025

Dec 06, 2025

Aug Gainers: Can Cadrenal Therapeutics Inc stock deliver strong Q4 earnings2025 Sector Review & Daily Momentum Trading Reports - moha.gov.vn

Dec 06, 2025

Dec 05, 2025

Is Cadrenal Therapeutics Inc. stock safe for conservative investorsGap Up & Weekly Market Pulse Updates - Newser

Dec 05, 2025

Dec 05, 2025

Why Cadrenal Therapeutics Inc. stock attracts global investorsGap Up & Fast Entry Momentum Trade Alerts - Newser

Dec 05, 2025

Dec 03, 2025

The Technical Signals Behind (CVKD) That Institutions Follow - news.stocktradersdaily.com

Dec 03, 2025

Dec 02, 2025

Can Cadrenal Therapeutics Inc. stock deliver strong Q4 earningsQuarterly Portfolio Summary & Daily Stock Trend Watchlist - Newser

Dec 02, 2025

Dec 02, 2025

Cadrenal Therapeutics, Inc. (CVKD) Analyst insights, Price targets and Recommendations - Yahoo Finance UK

Dec 02, 2025

Dec 02, 2025

Cadrenal Therapeutics appoints PTC Therapeutics CMO to board By Investing.com - Investing.com Australia

Dec 02, 2025

Dec 01, 2025

Cadrenal Therapeutics appoints Dr. Lee Golden to board of directors - marketscreener.com

Dec 01, 2025

Dec 01, 2025

Cadrenal Therapeutics Appoints Dr. Golden to Board - TipRanks

Dec 01, 2025

Dec 01, 2025

Cadrenal Therapeutics Appoints New Director - TradingView

Dec 01, 2025

Dec 01, 2025

Cadrenal Therapeutics, Inc. Appoints Dr. Lee Scott Golden to Board of Directors - Quiver Quantitative

Dec 01, 2025

Dec 01, 2025

Cadrenal Therapeutics appoints PTC Therapeutics CMO to board - Investing.com

Dec 01, 2025

Dec 01, 2025

Cadrenal Therapeutics, Inc. Appoints Lee Scott Golden, M.D. as Independent Director and Member of Science and Technology Committee - marketscreener.com

Dec 01, 2025

Dec 01, 2025

Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors - Sahm

Dec 01, 2025

Nov 29, 2025

Is Cadrenal Therapeutics Inc. stock affected by interest rate hikes2025 Risk Factors & Real-Time Volume Spike Alerts - BỘ NỘI VỤ

Nov 29, 2025

Nov 28, 2025

Cadrenal Therapeutics (CVKD) Stock Price, News & Analysis - MarketBeat

Nov 28, 2025

Nov 27, 2025

Will Cadrenal Therapeutics Inc. stock sustain high P E ratiosWeekly Investment Summary & Smart Allocation Stock Tips - BỘ NỘI VỤ

Nov 27, 2025

Nov 22, 2025

Precision Trading with Cadrenal Therapeutics Inc. (CVKD) Risk Zones - news.stocktradersdaily.com

Nov 22, 2025

Nov 19, 2025

Why Cadrenal Therapeutics Inc. stock could see breakout soonJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com

Nov 19, 2025

Nov 19, 2025

Institutional scanner results for Cadrenal Therapeutics Inc.2025 Earnings Impact & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025

Nov 19, 2025

Is Cadrenal Therapeutics Inc. stock a good choice for value investors2025 Sector Review & Safe Entry Zone Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Cadrenal Therapeutics CEO, Quang X. Pham, Receives BioFlorida’s Executive of the Year Award - The Manila Times

Nov 19, 2025

Nov 19, 2025

Agilent Technologies (NYSE: A) Debuts Altura Ultra Inert HPLC With 2x Sensitivity - Stock Titan

Nov 19, 2025

Nov 19, 2025

Detecting price anomalies in Cadrenal Therapeutics Inc. with AITreasury Yields & Fast Gaining Stock Reports - newser.com

Nov 19, 2025

Nov 19, 2025

What the charts say about Cadrenal Therapeutics Inc. todayWatch List & Daily Stock Trend Watchlist - newser.com

Nov 19, 2025

Nov 18, 2025

Is Cadrenal Therapeutics Inc. stock attractive for retirement portfolios2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com

Nov 18, 2025

Nov 18, 2025

Cadrenal Therapeutics Receives Legal Opinion From Blank Rome LLP On ?Validity Of Share Offering - MarketScreener

Nov 18, 2025

Nov 18, 2025

Cadrenal Therapeutics Announces New Stock Offering Program - TipRanks

Nov 18, 2025

Nov 18, 2025

Cadrenal Therapeutics IncBlank Rome LLP issued legal opinion on $3,438,062 sharesSEC filing - MarketScreener

Nov 18, 2025

Nov 18, 2025

[8-K] Cadrenal Therapeutics, Inc. Reports Material Event | CVKD SEC FilingForm 8-K - Stock Titan

Nov 18, 2025

Nov 16, 2025

Price momentum metrics for Cadrenal Therapeutics Inc. explainedDividend Hike & AI Forecast for Swing Trade Picks - newser.com

Nov 16, 2025

Nov 16, 2025

Quantitative breakdown of Cadrenal Therapeutics Inc. recent move2025 Major Catalysts & Growth Focused Entry Reports - newser.com

Nov 16, 2025